Inventor
WITTY DAVID R
GB20 patents
⚠️ This page may combine multiple inventors who share the name “WITTY DAVID R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CONVERGENCE PHARMACEUTICALS
7 patentsUS9376445B2Jun 28, 2016
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS4 citations81
US9309254B2Apr 12, 2016
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS4 citations81
US10485801B2Nov 26, 2019
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS1 citations70
US10010551B2Jul 3, 2018
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS2 citations70
US9737536B2Aug 22, 2017
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS3 citations70
US9303032B2Apr 5, 2016
2-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulator
CONVERGENCE PHARMACEUTICALS0 citations49
US9376436B2Jun 28, 2016
2-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulators
CONVERGENCE PHARMACEUTICALS1 citations46
GLAXO GROUP LTD
6 patentsUS7601837B2Oct 13, 2009
Quinoline derivatives and their use as 5-HT6 ligands
GLAXO GROUP LTD15 citations92
US7452888B2Nov 18, 2008
Quinoline derivatives and their use as 5-ht6 ligands
GLAXO GROUP LTD23 citations92
US7977337B2Jul 12, 2011
Quinoline derivatives and their use as 5-HT6 ligands
GLAXO GROUP LTD11 citations91
US7799774B2Sep 21, 2010
Quinoline derivatives and their use as 5-HT6 ligands
GLAXO GROUP LTD11 citations91
US7439243B2Oct 21, 2008
Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders
GLAXO GROUP LTD9 citations84
US7439244B2Oct 21, 2008
Quinoline compounds and pharmeceutical compositions containing them
GLAXO GROUP LTD0 citations52